CDKN2A and lung carcinoma: Recent years have seen progress similar to that we document for LKB1 in a number of other lung cancer genes and cancer networks, such as EGFR, KRAS, p53, and CDKN2A (including both transcripts: p16Ink4a and INK4a/ARF).